Skip to Content Skip to Search

What we are working on

Across our three businesses, our focus on innovation is driving a broad pipeline – from the development of everyday healthcare products to life-saving medicines and vaccines. 


Our Pharmaceuticals R&D organization is focused on research across four therapy areas – two core areas where we already have strong leadership developing new medicines: Respiratory and HIV/infectious diseases; and two potential areas where we have ongoing development program: Oncology and immuno-inflammation.

We also invest significantly in broader early discovery research, incubating areas of science outside our four core therapy areas where we think there is the potential to develop transformational medicines. This currently includes research into neuroscience and global health. 

R&D update

On July 25, 2018 we announced our new approach to R&D focusing on science related to the immune system, the use of genetics and investments in advanced technologies.

Quarterly results


Our Vaccines R&D organization is developing innovative vaccines which have the potential to help reduce the burden of many communicable diseases. At our three global R&D hubs in Belgium, Italy and the USA we’re researching vaccines against bacterial, viral and parasitic pathogens.

90% of the vaccines in our pipeline are being developed in partnership with others. We have a long track record of collaborating with governments, healthcare providers, regulators, academic institutions, non-governmental organizations, vaccine producers and other key partners to tackle public health challenges around the world.

Consumer Healthcare

Our Consumer Healthcare R&D organization develops products in five categories: Oral Health, Pain Relief, Respiratory, Nutrition and Gastrointestinal and Skin Health.

Our focus is on building a strong, competitive pipeline of consumer-led, science-based innovation. Our pipeline is fueled by five global innovation hubs that bring together our R&D, marketing and consumer insights teams, enabling us to develop innovative products based on the everyday healthcare needs of our consumers.